Mathew J. Stephen

Mathew J. Stephen

Auto-generated profile, based on publicly available information

Mathew J. Stephen

Department of Biology, University of Rochester, Rochester, NY, United States

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
MSMathew J. Stephen
Mathew J. Stephen
BABaylor Akhavan
Baylor Akhavan
MCMelinda B Chu
Melinda B Chu
KAVITA BatraKAVITA Batra
KAVITA Batra
RSRoberto Sagaribay
Roberto Sagaribay
Diabetes mellitus is characterized by impaired glucose regulation, predisposing patients to both hyperglycemia and hypoglycemia. Hypoglycemia, particularly frequent in insulin-treated individuals, remains a serious but underrecognized complication. Remote patient monitoring (RPM) technologies, such as continuous glucose monitors, smartphone apps, and hybrid closed-loop systems with remote monitoring capabilities, have emerged as promising tools to improve glycemic control and prevent hypoglycemia in nonclinical settings. Evidence examining the use of RPM technologies has expanded rapidly; however, the scope, characteristics, and reported outcomes of these interventions remain fragmented across modalities and settings. This scoping review aims to systematically map and describe the extent, range, and characteristics of published evidence on RPM interventions for glycemic management among adults with type 1 and type 2 diabetes in nonclinical settings. The review will follow the Joanna Briggs Institute scoping review methodology and adhere to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) reporting guidelines. The population, concept, and context framework defines the population as adults with type 1 or type 2 diabetes who experience or are at risk for hypoglycemia; the concept as RPM techniques (continuous glucose monitors, hybrid closed-loop systems with remote monitoring capabilities, telemedicine, and smartphone apps); and the context as nonclinical environments. The PubMed, Embase, and Scopus databases will be searched, supplemented by gray literature. Eligible studies will include clinical trials, observational studies, and cohort studies; reviews, case studies, and non-English articles will be excluded. Two independent reviewers will conduct screening, data extraction, and summarization. Findings will be synthesized descriptively in tabular and narrative formats. At the time of submission, the protocol has been registered, and the formal search strategy is being finalized. As of March 2026, the formal database search has been completed, and screening of studies is scheduled to begin in April 2026. This protocol outlines a structured approach to mapping the current landscape of RPM interventions for glycemic management in nonclinical settings. The completed review will synthesize reported intervention characteristics and outcomes to clarify existing evidence and identify areas for future investigation. OSF Registries 10.17605/OSF.IO/XNBWF; https://osf.io/xnbwf/overview. PRR1-10.2196/88197.

20 November 2025 in JMIR Preprints
Verified
Preprint
Open access
MSMathew J. Stephen
Mathew J. Stephen
BABaylor Akhavan
Baylor Akhavan
MCMelinda B Chu
Melinda B Chu
KAVITA BatraKAVITA Batra
KAVITA Batra
RSRoberto Sagaribay
Roberto Sagaribay
BACKGROUND Diabetes mellitus is characterized by impaired glucose regulation, predisposing patients to both hyperglycemia and hypoglycemia. Hypoglycemia, particularly frequent in insulin-treated individuals, remains a serious but under-recognized complication. Remote patient monitoring (RPM) technologies, such as continuous glucose monitors (CGMs), smartphone applications, and artificial pancreas systems, have emerged as promising tools to improve glycemic control and prevent hypoglycemia in non-clinical settings. Despite rapid technological advances, evidence on the scope, effectiveness, and limitations of these interventions remains fragmented. OBJECTIVE This scoping review aims to comprehensively map existing evidence on RPM tools for diabetes management, with a particular focus on hypoglycemia prevention in patients with type 1 and type 2 diabetes in home and outpatient environments. METHODS The review will follow the Joanna Briggs Institute (JBI) scoping review framework and adhere to the PRISMA-ScR reporting guidelines. The PCC framework defines the population as adults with type 1 or type 2 diabetes, the concept as RPM techniques (CGMs, artificial pancreas systems, telemedicine, smartphone apps), and the context as non-clinical environments. PubMed, Embase, and Scopus will be searched, supplemented by gray literature. Eligible studies will include clinical trials, observational studies, and cohort studies; reviews, case studies, and non-English articles will be excluded. Two independent reviewers will conduct screening, data extraction, and quality assessment. Findings will be synthesized descriptively in tabular and narrative formats. RESULTS We expect to identify diverse RPM approaches, summarize their outcomes on glycemic control, hypoglycemia reduction, and patient engagement, and highlight evidence gaps regarding usability, equity, and long-term safety. CONCLUSIONS This review will provide a comprehensive evidence map of RPM strategies for diabetes care, informing clinical practice, technology adoption, and future research directions.